Results 41 to 50 of about 50,453 (194)

Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana

open access: yesJournal of Infection in Developing Countries, 2013
Introduction: Oropharyngeal candidiasis is a common occurrence in the course of human immunodeficiency virus (HIV) disease progression. Changes in the clinical severity of oropharyngeal candidiasis and type of Candida species profile may be a reflection
Francis Kwamin   +3 more
doaj   +1 more source

The association between Candida albicans sensitivity to antimycotic drugs and the architecture of their microbial community in the oropharynx of HIV infected patients

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2023
Relevance. Candida infection remains relevant due to the wide spread of antimycotic-resistant strains of Candida fungi, especially among immunocompromised individuals. It was previously discovered that the Candida spp.
Yuri V. Nesvizhsky   +8 more
doaj   +1 more source

EphA2 Is a Neutrophil Receptor for Candida albicans that Stimulates Antifungal Activity during Oropharyngeal Infection

open access: yesCell Reports, 2019
Summary: During oropharyngeal candidiasis (OPC), Candida albicans proliferates and invades the superficial oral epithelium. Ephrin type-A receptor 2 (EphA2) functions as an oral epithelial cell β-glucan receptor that triggers the production of ...
Marc Swidergall   +7 more
doaj   +1 more source

Evaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC

open access: yesIranian Journal of Microbiology, 2023
Background and Objectives: Candida tropicalis is one of the major non-albicans species causing nosocomial infection. There is limited data about mechanisms of azole-resistance and virulence factors of Candida tropicalis.
Zahra Jahanshiri   +2 more
doaj   +1 more source

Isolation of Candida africana in oral candidiasis: First report among cancer patients in Iran [PDF]

open access: yesCurrent Medical Mycology, 2020
Background and Purpose: Oropharyngeal candidiasis (OPC) is a fungal infection of the oral cavity caused by the members of C. albicans complex. Although C.
Ensieh lotfali   +6 more
doaj   +1 more source

Risk factors for developing mucosal candidiasis of the upper gastrointestinal tract. The problem of antibiotic therapy

open access: yesGastroenterologìa, 2019
Background. According to the literature, there are a number of factors causing the development of candidiasis of the upper digestive tract; however, their significance in the formation of the disease has not been fully determined.
I.V. Kushnirenko
doaj   +1 more source

Development and evaluation of miconazole mucoadhesive tablets for oropharyngeal candidiasis [PDF]

open access: yes, 2017
Purpose: To develop mucoadhesive tablets containing miconazole (MCZ) for the treatment of oropharyngeal candidiasis, using chitosan and hydroxypropyl methylcellulose (HPMC) as mucoadhesive polymers.Methods: Mucoadhesive tablets were formulated and ...
Chen, Wei, Wu, Wan, Jin, Qiong
core   +1 more source

Cold plasma treatment for oral lichen planus: a retrospective case collection and proposal of a new clinical score

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Oral lichen planus (OLP) is a chronic autoimmune mucosal disease with malignant potential and limited treatment options. This study evaluated the long‐term efficacy and safety of cold atmospheric plasma (CAP) therapy in therapy‐refractory OLP and introduced the novel Lichen Planus Severity Score (LPSS).
Christian Seebauer   +5 more
wiley   +1 more source

New opportunities for complex treatment of oropharyngeal candidiasis in HIV-infected patients in the later stages of the disease

open access: yesТерапевтический архив, 2023
Treatment of recurrent oropharyngeal candidiasis (OPC) in HIV-infected patients is a serious clinical problem due to the emergence of resistant Candida strains, the risk of invasive disease, and high economic costs, which warrants the need for new ...
Artem O. Charushin   +2 more
doaj   +1 more source

Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS/TEN

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This international Delphi study achieved expert consensus on 58 statements guiding the management of oral involvement in autoimmune bullous diseases, erythema multiforme and SJS‐TEN. The recommendations emphasize multidisciplinary care, oral hygiene and tailored topical, systemic and inpatient oral management.
Shalini Nayee   +39 more
wiley   +1 more source

Home - About - Disclaimer - Privacy